Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study

被引:122
|
作者
Sinn, Dong Hyun [1 ]
Kang, Danbee [2 ]
Jang, Hye Ryoun [1 ]
Gu, Seonhye [3 ]
Cho, Soo Jin [4 ]
Paik, Seung Woon [1 ]
Ryu, Seungho [5 ]
Chang, Yoosoo [5 ]
Lazo, Mariana [6 ,7 ,8 ]
Guallar, Eliseo [3 ,6 ,7 ,8 ]
Cho, Juhee [2 ,3 ,6 ,7 ,8 ]
Gwak, Geum-Youn [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, 81 Irwon Ro, Seoul 06351, South Korea
[2] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, 81 Irwon Ro, Seoul 06351, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea
[4] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea
[5] Kangbuk Samsung Hosp, Ctr Total Hlth Studies, Seoul, South Korea
[6] Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA
[7] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[8] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA
关键词
Chronic kidney disease; Cohort; Fatty liver; Liver fibrosis; VITAMIN-D-RECEPTOR; HEPATIC STEATOSIS; FIBROSIS; PREVALENCE; NAFLD; RISK; MECHANISMS; HISTOLOGY;
D O I
10.1016/j.jhep.2017.08.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) has been associated with chronic kidney disease (CKD), but cohort studies are limited. We investigated the longitudinal association of NAFLD and its severity with the development of CKD. Methods: We performed a retrospective cohort study of 41,430 adult men and women (average age, 48.9 y) without CKD at baseline who underwent repeated health check-up examinations from January 1, 2003, through December 31, 2013. NAFLD status was assessed by ultrasonography, and NAFLD severity was assessed by the NAFLD fibrosis score (NFS). Results: The outcome was an incident CKD, defined as an estimated glomerular filtration rate less than 60 ml/min/1.73 m(2). During 200,790 person-years of follow-up (median follow-up of 4.15 years), we identified 691 incident CKD cases. The multivariable-adjusted hazard ratio for CKD comparing participants with and without NAFLD was 1.22 (95% confidence interval [CI] 1.04-1.43). The risk of CKD increased progressively with increased NAFLD severity. The multivariable-adjusted hazard ratios for CKD comparing participants with NFS < - 1.455 and those with NFS >= - 1.455 to participants without NAFLD were 1.09 (95% CI 0.91-1.32) and 1.58 (95% CI 1.30-1.92), respectively. The association was consistent across clinically relevant subgroups. Conclusion: In a large cohort of adult men and women without CKD, NAFLD was associated with an increased risk of CKD development. NAFLD may adversely affect renal function and patients may need to be carefully monitored for an increased risk of CKD. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1274 / 1280
页数:7
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
    Heda, Rajiv
    Yazawa, Masahiko
    Shi, Michelle
    Bhaskaran, Madhu
    Aloor, Fuad Zain
    Thuluvath, Paul J.
    Satapathy, Sanjaya K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (17) : 1864 - 1882
  • [32] Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
    Rajiv Heda
    Masahiko Yazawa
    Michelle Shi
    Madhu Bhaskaran
    Fuad Zain Aloor
    Paul J Thuluvath
    Sanjaya K Satapathy
    World Journal of Gastroenterology, 2021, 27 (17) : 1864 - 1882
  • [33] Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver
    Golmohammadi, Sima
    Tavasolil, Marjan
    Asadi, Nadia
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 299 - 304
  • [34] Fibrotic burden in non-alcoholic fatty liver disease independently predicts the chronic kidney disease incidence: A large prospective cohort study
    Chon, Young Eun
    Hwang, Seong-Gyu
    Rim, Kyu Sung
    Kim, Mi Na
    Park, Hana
    Lee, Yun Bin
    Lee, Ju Ho
    Ha, Yeonjung
    Lee, Mi Jung
    Kyu, Seong
    HEPATOLOGY, 2017, 66 : 1170A - 1170A
  • [35] Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
    Targher, G.
    Gisondi, P.
    Zoppini, G.
    Girolomoni, G.
    DIABETOLOGIA, 2009, 52 : S488 - S488
  • [36] Non-alcoholic fatty liver disease in chronic hepatitis B patients
    Karacaer, Zehra
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (04): : 395 - 395
  • [37] Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
    Gisondi, P.
    Targher, G.
    Zoppini, G.
    Girolomoni, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S24 - S24
  • [38] Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
    Gisondi, Paolo
    Targher, Giovanni
    Zoppini, Giacomo
    Girolomoni, Giampiero
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 758 - 764
  • [39] Alcoholic and non-alcoholic fatty liver disease and liver-related mortality: A cohort study
    Cho, Yong Kyun
    Kim, Keonhwa
    Chang, Yoosoo
    Cho, Juhee
    Jung, Hyun-Suk
    Yun, Kyung Eun
    Ahn, Jiin
    Ryu, Seungho
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E189 - E189
  • [40] Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Kanbay, Mehmet
    Bulbul, Mustafa C.
    Copur, Sidar
    Afsar, Baris
    Sag, Alan A.
    Siriopol, Dimitrie
    Kuwabara, Masanari
    Badarau, Silvia
    Covic, Adrian
    Ortiz, Alberto
    JOURNAL OF NEPHROLOGY, 2021, 34 (03) : 649 - 659